Pasithea Therapeutics Corp. (KTTA) has 12 open-market insider trades by 8 insiders since 2022. Over the last six months insiders net bought $53K. The most active filer is Camac Fund, LP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Camac Fund, LP via Eric Shahinian | — | — | 3 | $685K | 2022-09-29 |
| Lawrence Steinman | Dir | — | 2 | $213K | 2025-11-28 |
| Leonite Capital LLC | — | — | 1 | $142K | 2022-08-19 |
| Coastlands Capital LP | 10% Owner | — | 1 | $53K | 2026-06-17 |
| Camac Capital, LLC | — | — | 1 | $26K | 2022-08-30 |
| Tiago Marques | CEO | — | 2 | $26K | 2025-11-28 |
| Simon Dumesnil | Dir | — | 1 | $25K | 2025-11-28 |
| David Delaney | — | — | 1 | $1K | 2022-10-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Coastlands Capital LP | 10% Owner | Buy | $53K | 2026-06-17 |
| Simon Dumesnil | Director | Buy | $25K | 2025-11-28 |
| Lawrence Steinman | Director | Buy | $200K | 2025-11-28 |
| Tiago Marques | CEO | Sell | $797 | 2025-05-12 |
| Lawrence Steinman | Director | Buy | $13K | 2023-06-02 |
| David Delaney | — | Buy | $1K | 2022-10-17 |
Companies that share insiders with KTTA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Camac Fund, LP | — | Buy | $145K | 2022-09-28 |
| Camac Fund, LP | — | Buy | $163K | 2022-09-01 |
| Camac Capital, LLC | — | Buy | $26K | 2022-08-29 |
| Leonite Capital LLC | — | Buy | $142K | 2022-08-19 |
| Camac Fund, LP | — | Buy | $377K | 2022-08-17 |